KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Trends Analyst Outlook Journalist POV

45 hedge funds and large institutions have $42.5M invested in KalVista Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$350K
2
+$269K
3
+$226K
4
PVI
Pura Vida Investments
New York
+$143K
5
MC
Menta Capital
California
+$115K

Top Sellers

1
-$395K
2
-$275K
3
-$164K
4
Goldman Sachs
Goldman Sachs
New York
-$105K
5
VKH
Virtu KCG Holdings
New York
-$87K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$80K
27
$66K
28
$63K
29
$57K
30
$46K
31
$40K
32
$35K
33
$28K
34
$26K
35
$23K
36
$16K
37
$13K
38
$9.86K
39
$6K
40
$2K
41
$4
42
–
43
–
44
–
45
–
1
2